Women of reproductive age in the COVID-19 active research experiment (CARE) registry

Emily W. Bratton, Nancy A Dreyer(IQVIA (United Kingdom)), Natalia Petruski‐Ivleva(AVEO Oncology (United States)), Laura A. Albert(University of Wisconsin System)

Pharmacoepidemiology and Drug Safety

January 1, 2021

Cited by 0

Related Papers

Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study

|Journal of Renal Nutrition|2017|254

Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms

|Pharmacoepidemiology and Drug Safety|2020|120

Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults

|Annals of the Rheumatic Diseases|2023|95

Methods for external control groups for single arm trials or <scp>long‐term</scp> uncontrolled extensions to randomized clinical trials

|Pharmacoepidemiology and Drug Safety|2020|68

Depression, Anxiety, and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-Cohort Study

|American Journal of Epidemiology|2020|66